Infecciones asociadas a la atención sanitaria causadas por Candida spp. en neonatos críticos: un análisis de las superficies ambientales
DOI:
https://doi.org/10.17058/reci.v14i4.19358Palabras clave:
Infecciones Fúngicas Invasoras, Infección Hospitalaria, Control de Infecciones, Salud del LactanteResumen
Justificación y Objetivos: las infecciones fúngicas invasivas conllevan altas tasas de morbilidad y mortalidad en las Unidades de Cuidados Intensivos Neonatales (UCINs) y están acompañadas por un aumento en la prevalencia de aislamientos resistentes, destacando el ambiente hospitalario como la principal fuente de contaminación. Este estudio identificado las especies de Candida en neonatos en una UCIN brasileña, evaluó sus condiciones clínicas y de laboratorio y caracterizó los aislamientos. Métodos: se identificaron y analizaron los aislamientos de Candida de recién nacidos (RNs) y del ambiente en relación con la resistencia antifúngica, los factores de virulencia y las relaciones moleculares. Resultados: cuatro RNs presentaron candidiasis invasiva, como C. albicans (2 RNs), C. glabrata (1 RN) y C. parapsilosis sensu stricto (1 RN). Todos los RNs eran extremadamente prematuros (<29 semanas) y habían utilizado al menos un dispositivo invasivo. Dos aislamientos clínicos demostraron resistencia, uno al fluconazol (C. parapsilosissensu stricto) y el otro a la micafungina (C. glabrata). Cinco aislamientos ambientales se identificaron como C. parapsilosis sensu stricto, y uno de ellos mostró susceptibilidad dependiente de la dosis al fluconazol. El biofilm fue el único factor de virulencia producido por los nueve aislamientos. El análisis molecular reveló una alta similitud entre un aislamiento ambiental y uno clínico de C. parapsilosis sensu stricto. Conclusión: los resultados indicaron la presencia de especies de Candida en neonatos y en el ambiente de la UCIN, con algunas mostrando resistencia in vitro al fluconazol y a la micafungina. Todos los aislamientos produjeron biofilm. Se observó una notable similitud genética entre algunos aislamientos ambientales y clínicos, lo que sugiere que el ambiente podría ser una posible fuente de infección.
Descargas
Citas
Rakshit P, Nagpal N, Sharma S, et al. Effects of implementation of healthcare associated infection surveillance and interventional measures in the neonatal intensive care unit: Small steps matter. Indian Journal of Medical Microbiology. 2023; 44:100369. https://doi.org/10.1016/j.ijmmb.2023.100369.
Miyake A, Gotoh K, Iwahashi J, et al. Characteristics of Biofilms Formed by C. parapsilosis Causing an Outbreak in a Neonatal Intensive Care Unit. Journal of Fungi. 2022; 8(7). https://doi.org/10.3390/jof8070700.
Menezes RP, Melo SGO, Bessa MAS, et al. Candidemia by Candida parapsilosis in a neonatal intensive care unit: human and environmental reservoirs, virulence factors, and antifungal susceptibility. Braz J Microbiol. 2020; 51(3):851–60. https://doi.org/10.1007/s42770-020-00232-1.
Hsiao-Chuan L, Hsiang-Yu L, Bai-Hong S, et al. Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit. Journal of microbiology, immunology, and infection. 2013; 46(6):456-62. http://dx.doi.org/10.1016/j.jmii.2012.07.013
Riera FO, Caeiro JP, Angiolini SC, et al. Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America. Antibiotics. 2022; 11(7). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312041/.
Elkady MA, Bakr WMK, Ghazal H, et al. Role of environmental surfaces and hands of healthcare workers in perpetuating multi-drug-resistant pathogens in a neonatal intensive care unit. Eur J Pediatr. 2022; 181(2):619–28. https://doi.org/10.1007/s00431-021-04241-6.
Daneshnia F, Júnior JNA, Ilkit M, et al. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. The Lancet Microbe. 2023; 4(6):e470–80. https://doi.org/10.1016/ S2666-5247(23)00067-8.
Nagarathnamma T, Chunchanur SK, Rudramurthy SM, et al. Outbreak of Pichia kudriavzevii fungaemia in a neonatal intensive care unit. Journal of Medical Microbiology. 2017; 66(12):1759–64. https://doi.org/10.1099/jmm.0.000645.
Qi L, Fan W, Xia X, et al. Nosocomial outbreak of Candida parapsilosis sensu stricto fungaemia in a neonatal intensive care unit in China. Journal of Hospital Infection. 2018; 100(4):e246–52. https://doi.org/10.1016/j.jhin.2018.06.009.
Riceto ÉBM, Menezes RP, Penatti MPA, et al. Enzymatic and hemolytic activity in different Candida species. Revista Iberoamericana de Micología. 2015; 32(2):79–82. https://dx.doi.org/10.1016/j.riam.2013.11.003.
Zhang Z, Cao Y, Li Y, Chen X, et al. Risk factors and biofilm formation analyses of hospital-acquired infection of Candida pelliculosa in a neonatal intensive care unit. BMC Infect Dis. 2021; 21(1):1–11. https://doi.org/10.1186/s12879-021-06295-1,
O’Leary EN, Edwards JR, Srinivasan A, et al. National Healthcare Safety Network 2018 Baseline Neonatal Standardized Antimicrobial Administration Ratios. Hosp Pediatr. 2022; 12(2):190–8. https://doi.org/10.1542/hpeds.2021-006253.
Menezes RP, Marques LA, Silva FF, et al. Inanimate Surfaces and Air Contamination with Multidrug Resistant Species of Staphylococcus in the Neonatal Intensive Care Unit Environment. Microorganisms. 2022; 10(3):567. https://doi.org/10.3390/microorganisms10030567.
Suleyman G, Alangaden G, Bardossy AC. The Role of Environmental Contamination in the Transmission of Nosocomial Pathogens and Healthcare-Associated Infections. Curr Infect Dis Rep. 2018; 20(6):1–11. https://doi.org/10.1007/s11908-018-0620-2.
Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. Document M27-S4. Clinical and Laboratory Standards Institute; 2012. https://clsi.org/media/1897/m27ed4_sample.pdf
Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard-M27-A3-S3. Clinical and Laboratory Standards Institute; 2008. https://clsi.org/media/1461/m27a3_sample.pdf
NCCLS. Método de Referência para Testes de Diluição em Caldo para a Determinação da Sensibilidade a Terapia Antifúngica das Leveduras; Norma Aprovada—Segunda Edição. NCCLS document M27-A2 [ISBN 1-56238-469-4]. 2o ed. EUA; 2002. https://bvsms.saude.gov.br/bvs/publicacoes/metodo_ref_testes_diluicao_modulo2.pdf
Stefan S, Peter S, Shabbir S, et al. Assessing the antimicrobial susceptibility of bacteria obtained from animals. Veterinary Microbiology. 2010; 141(1–2):1–4. https://doi.org/10.1016/j.vetmic.2009.12.013.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antifungal Susceptibility Testing of Yeasts. 1st ed. CLSI supplement M60. 1o ed. Wayne: CLSI; 2017. https://clsi.org/media/1895/m60ed1_sample.pdf
Clinical and Laboratory Standards Institute (CLSI). Epidemiological cutoff values for antifungal susceptibility testing. 2nd ed. CLSI supplement, M59. 2o ed. Clinical and Laboratory Standards Institute; 2018. https://clsi.org/media/1934/m59ed2_sample-updated.pdf
Pfaller MA, Diekema DJ. Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012. Journal of Clinical Microbiology. 2012; 50(9). https://doi.org/10.1128/jcm.00937-12.
Costa-Orlandi CB, Sardi JCO, Santos CT, et al. In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms. Biofouling 2014; 30:6, 719-727. https://doi.org/10.1080/08927014.2014.919282.
Pierce CG, Uppuluri P, Tristan AR, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3(9):1494–500. https://doi.org/10.1038/nprot.2008.141.
Marcos-Zambrano L, Pilar E, Emilio B, et al. Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points. International journal of medical microbiology : IJMM. 2014; 304(8). https://doi.org/10.1016/j.ijmm.2014.08.012.
Menezes PR, Silva FF, Melo SGO, et al. Characterization of Candida species isolated from the hands of the healthcare workers in the neonatal intensive care unit. Med Mycol. 2019; 57(5):588–94. https://doi.org/10.1093/mmy/myy101.
Riceto ÉBM, Menezes RP, Röder DVDB, et al. Molecular profile of oral Candida albicans isolates from hiv-infected patients and healthy persons. International Journal of Development Research (IJDR). 2017:14432–6. https://www.journalijdr.com/sites/default/files/issue-pdf/9523.pdf.
Furin WA, Tran LH, Chan MY, et al. Sampling efficiency of Candida auris from healthcare surfaces: culture and nonculture detection methods. Infection Control & Hospital Epidemiology. 2022; 43(10):1492–4. https://doi.org/10.1017/ice.2021.220.
##submission.downloads##
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Priscila Guerino Vilela, Isadora Caixeta da Silveira Ferreira, Ralciane de Paula Menezes, Mário Paulo Amante Penatti, Reginaldo dos Santos Pedroso, Denise Von Dolinger de Brito Röder

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.